Natural Killer Cells in the Near Future of Immuno-Oncological Therapeutic Approaches
Author:
Tayebi Hend Mohamed El
Reference122 articles.
1. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA. Human natural killer cells: A unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97(10):3146-3151
2. Freud AG, Becknell B, Roychowdhury S, Mao HC, Ferketich AK, Nuovo GJ, Hughes TL, Marburger TB, Sung J, Baiocchi RA, Guimond M, Caligiuri MA. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity. 2005;22(3):295-304
3. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T. The trafficking of natural killer cells. Immunological Reviews. 2007;220:169-182
4. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nature Reviews. Cancer. 2002;2(11):850-861
5. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annual Review of Immunology. 2013;31:163-194